Sustained fetal tachyarrhythmia can evolve into a life-threatening condition in 40% of cases when hydrops develops, with a 27% risk of perinatal death. Several antiarrhythmic drugs can be given solely or in combination to the mother to achieve therapeutic transplacental concentrations. Therapeutic failure could lead to progressive cardiac insufficiency and restrict therapeutic options to either elective delivery or direct fetal administration of antiarrhythmic drugs, which may increase the risk of death. We report for the first time successful fetal transesophageal pacing to treat a hydropic fetus with drug-resistant tachyarrhythmia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajog.2018.07.018 | DOI Listing |
Publication Analysis
Top Keywords
transesophageal pacing
8
drug-resistant tachyarrhythmia
8
antiarrhythmic drugs
8
successful utero
4
utero transesophageal
4
pacing for severe
4
for severe drug-resistant
4
tachyarrhythmia sustained
4
sustained fetal
4
fetal tachyarrhythmia
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!